Clinical Trial VICCBMT1063


T-Regulatory Homing Subsets as a Predictor of Response in GVHD Treated with Extracorporeal Photopheresis

Principal Investigator(s)

Madan Jagasia


  • Protocol No. VICCBMT1063
  • Open Date: 07/27/2011
  • Staging: NA
  • Age Group: Adults
  • Scope: National
  • Objective: To show that ECP increases skin and gut homing T regulatory cells in patients with GVHD clinically responded to ECP
  • Disease Sites: Hematologic
  • Therapies: None Specified
  • Drugs: None Specified
  • Participating Institutions: Virginia Commonwealth University - Massey Cancer Center; Emory University; Dana-Farber Cancer Institute; Vanderbilt University
  • National Clinical Trial ID: NCT01324908
  • Secondary Protocol No: Not Specified



Learn More

You do not have JavaScript enabled. This site works better with JavaScript turned on.